Anthricin Isolated from Anthriscus sylvestris (L.) Hoffm. Inhibits the Growth of Breast Cancer Cells by Inhibiting Akt/mTOR Signaling, and Its Apoptotic Effects Are Enhanced by Autophagy Inhibition

Anthricin (deoxypodophyllotoxin) is a natural product isolated from Anthriscus sylvestris (L.) Hoffm. (Apiaceae). Here, we investigated the effect of anthricin on autophagy and mammalian target of rapamycin (mTOR) signaling as anticancer actions in breast cancer cells. Many studies have supported the contention that the phosphoinositide 3-kinase (PI3K)/Akt/mTORC1 pathway is considerably deregulated in breast cancer and that autophagy plays important roles in the development of this type of cancer, although the exact underlying mechanisms remain unknown. Our data confirmed that anthricin markedly induced apoptosis in 2 breast cancer cell lines, MCF7 (estrogen receptor positive) and MDA-MB-231 (estrogen receptor, progesterone receptor, and Her2/Neu receptor negative). Anthricin treatment decreased the levels of phosphorylated Akt and mTORC1, followed by inhibition of cell growth. Interestingly, blockage of autophagy by a pharmacological inhibitor or genetic deletion of ULK1 and Atg13 accelerated anthricin-induced apoptosis, suggesting that autophagy has cytoprotective effects. Taken together, our results indicate that anthricin is an inhibitor of mTOR and that a combination of an autophagy inhibitor and anthricin may serve as a new promising strategy for the treatment of breast cancer cells.

[1]  A. Aboussekhra.  Olive oil oleuropein has anti-breast cancer properties with higher efficiency on ER-negative cells , 2015 .

[2]  P. Srivastava,et al.  Resveratrol depletes mitochondrial DNA and inhibition of autophagy enhances resveratrol-induced caspase activation. , 2013, Mitochondrion.

[3]  Kwang-Youn Kim,et al.  Interplay of reactive oxygen species, intracellular Ca2+ and mitochondrial homeostasis in the apoptosis of prostate cancer cells by deoxypodophyllotoxin , 2013, Journal of cellular biochemistry.

[4]  Gun-Hee Kim,et al.  Antiproliferative activity of daidzein and genistein may be related to ERα/c-erbB-2 expression in human breast cancer cells. , 2013, Molecular medicine reports.

[5]  G. Mariani,et al.  Novel approaches for molecular targeted therapy of breast cancer: interfering with PI3K/AKT/mTOR signaling. , 2013, Current cancer drug targets.

[6]  E. White,et al.  Coordinate Autophagy and mTOR Pathway Inhibition Enhances Cell Death in Melanoma , 2013, PloS one.

[7]  Tabitha M. Hardy,et al.  Epigenetic Regulation of Multiple Tumor-Related Genes Leads to Suppression of Breast Tumorigenesis by Dietary Genistein , 2013, PloS one.

[8]  Yuquan Wei,et al.  Autophagy in tumorigenesis and cancer therapy: Dr. Jekyll or Mr. Hyde? , 2012, Cancer letters.

[9]  Yifan Dai,et al.  mTORC1 is a target of nordihydroguaiaretic acid to prevent breast tumor growth in vitro and in vivo , 2012, Breast Cancer Research and Treatment.

[10]  N. Teixeira,et al.  Apoptosis and Autophagy in Breast Cancer Cells following Exemestane Treatment , 2012, PloS one.

[11]  A. Lazar,et al.  Targeting the PI3K/mTOR Axis, Alone and in Combination with Autophagy Blockade, for the Treatment of Malignant Peripheral Nerve Sheath Tumors , 2012, Molecular Cancer Therapeutics.

[12]  Robert Clarke,et al.  Guidelines for the use and interpretation of assays for monitoring autophagy , 2012 .

[13]  J. Baselga,et al.  Dual Mtorc1/2 and Her2 Blockade Results in Antitumor Activity in Preclinical Models of Breast Cancer Resistant to Anti-her2 Therapy Statement of Translational Relevance , 2022 .

[14]  H. J. Woerdenbag,et al.  Seasonal variations in the deoxypodophyllotoxin content and yield of Anthriscus sylvestris L. (Hoffm.) grown in the field and under controlled conditions. , 2011, Journal of agricultural and food chemistry.

[15]  W. Mckeehan,et al.  Acetylated microtubules are required for fusion of autophagosomes with lysosomes , 2010, BMC Cell Biology.

[16]  N. Uehara,et al.  Autophagy inhibition enhances sulforaphane-induced apoptosis in human breast cancer cells. , 2010, Anticancer research.

[17]  Jemma L. Webber,et al.  Trafficking and signaling in mammalian autophagy , 2010, IUBMB life.

[18]  Chang Gun Kim,et al.  Deoxypodophyllotoxin induces G2/M cell cycle arrest and apoptosis in HeLa cells. , 2010, Cancer letters.

[19]  Y. Lim,et al.  Antitumor activity of deoxypodophyllotoxin isolated from Anthriscus sylvestris: Induction of G2/M cell cycle arrest and caspase-dependent apoptosis. , 2009, Bioorganic & medicinal chemistry letters.

[20]  David R Bickers,et al.  Multiple molecular targets of resveratrol: Anti-carcinogenic mechanisms. , 2009, Archives of biochemistry and biophysics.

[21]  C. Jung,et al.  ULK-Atg13-FIP200 complexes mediate mTOR signaling to the autophagy machinery. , 2009, Molecular biology of the cell.

[22]  V. Androutsopoulos,et al.  Antiproliferative and cytostatic effects of the natural product eupatorin on MDA-MB-468 human breast cancer cells due to CYP1-mediated metabolism , 2008, Breast Cancer Research.

[23]  Mari Haramoto,et al.  Isolation of Apoptosis- and Differentiation-Inducing Substances toward Human Promyelocytic Leukemia HL-60 Cells from Leaves of Juniperus taxifolia , 2008, Bioscience, biotechnology, and biochemistry.

[24]  G. Jeong,et al.  Lignans and coumarins from the roots of Anthriscus sylvestris and their increase of caspase-3 activity in HL-60 cells. , 2007, Biological & pharmaceutical bulletin.

[25]  N. Mizushima,et al.  How to Interpret LC3 Immunoblotting , 2007, Autophagy.

[26]  G. Stark,et al.  Control of the G2/M transition , 2006, Molecular biotechnology.

[27]  Y. Kondo,et al.  Autophagy and Cancer Therapy , 2006, Autophagy.

[28]  D. Sabatini,et al.  mTOR Interacts with Raptor to Form a Nutrient-Sensitive Complex that Signals to the Cell Growth Machinery , 2002, Cell.

[29]  B. Ahn,et al.  Deoxypodophyllotoxin; the cytotoxic and antiangiogenic component from Pulsatilla koreana. , 2002, Planta medica.

[30]  F. Cognetti,et al.  The Mammalian target of rapamycin inhibitors in breast cancer: current evidence and future directions. , 2013, Anticancer research.

[31]  A. Lazar,et al.  Targeting the PI 3 K / mTOR Axis , Alone and in Combination with Autophagy Blockade , for the Treatment of Malignant Peripheral Nerve Sheath Tumors , 2012 .

[32]  W. Marsden.  I and J , 2012 .

[33]  J. Baselga.  Targeting the phosphoinositide-3 (PI3) kinase pathway in breast cancer. , 2011, The oncologist.